In light of "encouraging developments" in clinical trials and the expected regulatory approval of a COVID-19 vaccine, vaccination centers across Germany would be...
Ogbuagu, an Associate Professor of Medicine and Infectious Diseases at Yale School of Medicine, is one of those leading the Pfizer trial. Earlier in the month,...
Today, the U.S. Food and Drug Administration approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1), a rare genetic disorder.
While respiratory issues continue to be the most common symptom of a COVID-19 infection, new research indicates the disease could also be associated with hypercoagulability,...
Results of a new study show that opioid overdose deaths involving more than one substance (polysubstances) are more common than opioid-only overdose deaths among...
At the 73rd Annual Meeting of the American Physical Society's Division of the Americal Physical Society's Division of Fluid Dynamics, researchers presented a range...
Henrietta Fore (C), Executive Director of the United Nations Children’s Fund (UNICEF), addresses a discussion on vaccine misinformation and growing distrust at the UN headquarters in...
[Courtesy of SK Bioscience]SEOUL -- SK Bioscience, a cooperation partner for South Koreas state project to develop COVID-19 vaccines, will immediately embark on...
Researchers have used cutting edge technology to bioprint miniature human kidneys in the lab, paving the way for new treatments for kidney failure and possibly...
I slapped him hard.